持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/09/22 | 8,320 | 8,360 | 8,210 | 8,230 | -110 | -1.3% | 31,000 |
| 2017/09/21 | 8,320 | 8,420 | 8,320 | 8,340 | -10 | -0.1% | 26,000 |
| 2017/09/20 | 8,390 | 8,440 | 8,320 | 8,350 | -50 | -0.6% | 19,600 |
| 2017/09/19 | 8,270 | 8,410 | 8,260 | 8,400 | +200 | +2.4% | 36,200 |
| 2017/09/15 | 8,170 | 8,250 | 8,160 | 8,200 | +20 | +0.2% | 35,900 |
| 2017/09/14 | 8,210 | 8,230 | 8,170 | 8,180 | ±0 | ±0% | 13,700 |
| 2017/09/13 | 8,170 | 8,200 | 8,150 | 8,180 | ±0 | ±0% | 11,900 |
| 2017/09/12 | 8,230 | 8,250 | 8,160 | 8,180 | -10 | -0.1% | 22,000 |
| 2017/09/11 | 8,160 | 8,220 | 8,120 | 8,190 | +130 | +1.6% | 28,200 |
| 2017/09/08 | 8,050 | 8,110 | 8,050 | 8,060 | -50 | -0.6% | 36,100 |
| 2017/09/07 | 8,180 | 8,220 | 8,100 | 8,110 | -40 | -0.5% | 20,000 |
| 2017/09/06 | 8,000 | 8,170 | 8,000 | 8,150 | ±0 | ±0% | 26,000 |
| 2017/09/05 | 8,250 | 8,310 | 8,140 | 8,150 | -150 | -1.8% | 24,300 |
| 2017/09/04 | 8,420 | 8,440 | 8,300 | 8,300 | -190 | -2.2% | 24,500 |
| 2017/09/01 | 8,500 | 8,520 | 8,440 | 8,490 | +80 | +1% | 25,800 |
| 2017/08/31 | 8,480 | 8,480 | 8,380 | 8,410 | -30 | -0.4% | 25,900 |
| 2017/08/30 | 8,340 | 8,450 | 8,340 | 8,440 | +110 | +1.3% | 20,400 |
| 2017/08/29 | 8,170 | 8,350 | 8,170 | 8,330 | +40 | +0.5% | 28,200 |
| 2017/08/28 | 8,210 | 8,290 | 8,180 | 8,290 | +140 | +1.7% | 24,100 |
| 2017/08/25 | 8,130 | 8,200 | 8,120 | 8,150 | +40 | +0.5% | 15,200 |
| 2017/08/24 | 8,170 | 8,170 | 8,090 | 8,110 | -60 | -0.7% | 12,500 |
| 2017/08/23 | 8,210 | 8,210 | 8,140 | 8,170 | +50 | +0.6% | 16,200 |
| 2017/08/22 | 8,080 | 8,180 | 8,070 | 8,120 | -20 | -0.2% | 19,700 |
| 2017/08/21 | 8,080 | 8,150 | 8,080 | 8,140 | +10 | +0.1% | 12,300 |
| 2017/08/18 | 8,060 | 8,150 | 8,030 | 8,130 | -80 | -1% | 20,500 |
| 2017/08/17 | 8,150 | 8,220 | 8,120 | 8,210 | +10 | +0.1% | 19,700 |
| 2017/08/16 | 8,160 | 8,240 | 8,110 | 8,200 | +30 | +0.4% | 28,400 |
| 2017/08/15 | 8,180 | 8,210 | 8,120 | 8,170 | +30 | +0.4% | 21,200 |
| 2017/08/14 | 8,190 | 8,220 | 8,100 | 8,140 | -160 | -1.9% | 34,400 |
| 2017/08/10 | 8,100 | 8,300 | 8,100 | 8,300 | +230 | +2.9% | 53,400 |
| 2017/08/09 | 8,160 | 8,180 | 8,010 | 8,070 | -90 | -1.1% | 40,500 |
| 2017/08/08 | 8,180 | 8,240 | 8,140 | 8,160 | -50 | -0.6% | 31,300 |
| 2017/08/07 | 8,080 | 8,210 | 8,080 | 8,210 | +140 | +1.7% | 44,600 |
| 2017/08/04 | 8,060 | 8,080 | 8,040 | 8,070 | +20 | +0.2% | 25,400 |
| 2017/08/03 | 8,040 | 8,070 | 8,000 | 8,050 | +10 | +0.1% | 21,300 |
| 2017/08/02 | 8,060 | 8,080 | 8,000 | 8,040 | +10 | +0.1% | 44,000 |
| 2017/08/01 | 7,750 | 8,050 | 7,710 | 8,030 | +340 | +4.4% | 72,500 |
| 2017/07/31 | 7,600 | 7,850 | 7,600 | 7,690 | +40 | +0.5% | 88,300 |
| 2017/07/28 | 7,600 | 7,650 | 7,590 | 7,650 | +10 | +0.1% | 20,000 |
| 2017/07/27 | 7,620 | 7,680 | 7,610 | 7,640 | +20 | +0.3% | 24,100 |
| 2017/07/26 | 7,680 | 7,680 | 7,590 | 7,620 | -10 | -0.1% | 30,200 |
| 2017/07/25 | 7,610 | 7,650 | 7,610 | 7,630 | -20 | -0.3% | 18,600 |
| 2017/07/24 | 7,700 | 7,720 | 7,610 | 7,650 | -80 | -1% | 29,000 |
| 2017/07/21 | 7,760 | 7,780 | 7,720 | 7,730 | -90 | -1.2% | 25,500 |
| 2017/07/20 | 7,750 | 7,850 | 7,740 | 7,820 | +70 | +0.9% | 20,100 |
| 2017/07/19 | 7,760 | 7,790 | 7,710 | 7,750 | ±0 | ±0% | 39,200 |
| 2017/07/18 | 7,820 | 7,820 | 7,720 | 7,750 | -90 | -1.1% | 28,600 |
| 2017/07/14 | 7,860 | 7,870 | 7,810 | 7,840 | +30 | +0.4% | 30,600 |
| 2017/07/13 | 7,940 | 7,940 | 7,800 | 7,810 | -40 | -0.5% | 23,800 |
| 2017/07/12 | 7,940 | 7,940 | 7,840 | 7,850 | -40 | -0.5% | 25,600 |
1751～
1800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
